OPTILEUKIN
LIVE

Serial Number

99155128

Owner

InVitria, Inc.

Attorney

Dianne M. Smith-Misemer

Filing Date

Apr 25, 2025

Add to watchlist:

No watchlists yet
View on USPTO

OPTILEUKIN Trademark

Serial Number: 99155128

OPTILEUKIN is a trademark filed by InVitria, Inc. on April 25, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

InVitria, Inc.

2718 Industrial Drive
Junction City, KS 66441

Entity Type: 03

Trademark Details

Filing Date

April 25, 2025

Registration Date

Not Registered

Published for Opposition

October 21, 2025

Goods & Services

Recombinant cytokine proteins in raw material form for scientific and medical research use; Recombinant cytokine proteins for use in manufacture of pharmaceutical products, veterinary preparations, cellular therapies, gene therapies, regenerative medicines, and vaccines; Chemicals, namely, non-animal derived cell culture media for promoting cell growth, optimization, and productivity, for scientific and research use; Non-animal derived cell culture media for promoting cell growth, optimization, and productivity, for scientific, laboratory and medical research

Chemicals, namely, non-animal derived cell culture media for promoting cell growth, optimization, and productivity, for medical or veterinary purposes; Recombinant cytokine proteins for use as cell growth media for growing cells for clinical use; Recombinant cytokine proteins for use as reagents for clinical medical purposes; Recombinant cytokine protein arrays for clinical medical diagnosis purposes; Recombinant cytokine proteins sold as a component ingredient of therapeutic pharmaceuticals for the treatment of immune system related diseases and disorders; Recombinant cytokine proteins for use as reagents for medical use, for the optimization of in vitro expansion of cells; Pharmaceutical preparations, namely, cytokine drugs for the optimization of in vitro expansion of cells

Filing History

TEAS STATEMENT OF USE RECEIVED
Mar 31, 2026 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 16, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 21, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 21, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 15, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 22, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 22, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 22, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 22, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 22, 2025 CNEA
ASSIGNED TO EXAMINER
Sep 16, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 25, 2025 MAFR
NEW APPLICATION ENTERED
Apr 25, 2025 NWAP